Letter: systemic therapy for psoriasis could affect the prevalence of NAFLD

E-ISSN： 1365-2036|41|12|1301-1301

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.12, 2015-06, pp. : 1301-1301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy treatment options for psoriasis: topical and systemic

By Mikhail Maryann Scheinfeld Noah S

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 319-330

Future Medicine

Access to resources Recommend Favorite

The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US

By Crown William H. Bresnahan Brian W. Orsini Lucinda S. Kennedy Sean Leonardi Craig

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1929-1936

Informa Healthcare

Access to resources Recommend Favorite

Acute systemic sarcoidosis complicating ustekinumab therapy for chronic plaque psoriasis

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 834-836

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: call to screen for NAFLD and NASH in psoriasis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 492-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Joint Pains with Psoriasis and Long‐term Systemic Etretinate Therapy: A Case Report and Summary of 12 Cases

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 10, 1993-10 ,pp. : 651-653

John Wiley & Sons Inc

Access to resources Recommend Favorite